Back to mobile site

More on CRBU

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-20.0% Growth)
- Ratings (8.2 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Caribou Bioscience, Inc (NQ:CRBU)
Delayed: 1.44 -0.1 (6.49%)
Prev. Close $1.54  
Open$1.54 
52 Wk High$ 
52 Wk Low$ 
Day High$1.54 
Day Low$1.44 
P/E N/A  
EPS$ 
Volume1,466,910 

Friends, Peers and Foes (?): GTBP, LYEL, NRIX, SLS, CMPX (more...)

Aug 14, 2026 05:19 AM Caribou Biosciences Inc. (CRBU) PT Lowered to $5 at BofA Securities
Aug 13, 2026 04:13 PM Form 10-Q Caribou Biosciences, For: Jun 30
Aug 13, 2026 04:10 PM Form 8-K Caribou Biosciences, For: Aug 13
Aug 13, 2026 04:09 PM Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 7c
Aug 13, 2026 04:06 PM Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Jul 27, 2026 04:28 PM Form SCHEDULE 13G Caribou Biosciences, Filed by: BlackRock, Inc.
Jun 29, 2026 08:00 AM Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Jun 18, 2026 04:02 PM Form 8-K Caribou Biosciences, For: Jun 17
Jun 16, 2026 06:48 AM H.C. Wainwright Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU)
Jun 12, 2026 08:10 AM After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
View All Articles

Entities mentioned with CRBU

View All Entities